Corixa [CRXA] - cancer vaccines Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Corixa [CRXA] - cancer vaccines

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andreas Helke who started this subject	11/2/2000 10:57:57 AM
From: keokalani'nui	Read Replies (1) of 222

Todays PR regarding the RA vaccine looks promising, though efficacy was only measured against 20% improvement. Does anyone know offhand how to evaluate this study criteria? "Seven of nine patients randomized to AnergiX in each of the two highest dose levels, including one of two patients in the placebo group, were required at study entry to have T cell reactivity to CDP263, a peptide contained in the AnergiX.RA complex that is derived from human cartilage glycoprotein 39, found in synovial fluid and tissue of RA-inflamed joints." --Wilder

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next